| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4169168 | The Journal of Pediatrics | 2006 | 4 Pages |
Abstract
Fourteen children with uveitis (9 JIA associated and 5 idiopathic) were treated with adalimumab for an average of 18.1 months. Inflammation decreased in 21/26 eyes (80.8%), 4 eyes remained stable (15.4%), and 1 worsened (3.8%) (P < .001; 2 tailed paired Wilcoxon rank sum test). No significant adverse events occurred.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Perinatology, Pediatrics and Child Health
Authors
Liza B. Vazquez-Cobian, Thomas Flynn, Thomas J.A. Lehman,